Collaboration - May 10, 2021
Glooko collaborates with Eli Lilly
Glooko has announced a strategic collaboration with Eli Lilly and Company for people with diabetes that use Lilly’s connected insulin pen solutions. The technology collaboration will ease insulin management for people with diabetes and their healthcare providers in markets outside the U.S., via integration of Lilly’s Tempo Pen and Tempo Smart Button (currently in late-stage […]
Agreement - April 20, 2021
BC Platforms enters new partnership
BC Platforms has announced a new strategic partnership with US-based company TripleBlind to help drive the development of privacy and intellectual property rights (IPR) preserving “federated AI” for its BCRQUEST.com Global Data Partner Network. The partnership will enhance BCP’s contribution to the Finnish-led PRIVASA (Privacy Preserving AI for Synthetic and Anonymous Health Data) consortium, which […]
Financing - April 8, 2021
AlgoDx raises SEK 13 million
AlgoDx has announced that all existing investors have committed to a follow-up investment summing up to 13 MSEK (approximately 1.25 MEUR). The round was led by Nascent Invest with participation from angel investors Tomas Mora-Morrison, co-founder of Cambio Healthcare Systems, and Fredrik Sjödin. Accelerate projects The company intends to use the funds to continue to […]
Financing - March 17, 2021
Glooko raises USD 30 million
Glooko has raised a USD 30 million Series D round of funding. The financing was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic. The new proceeds will accelerate execution of Glooko’s commercial strategy, including increasing adoption of Glooko’s remote patient monitoring platform, widening […]
Clinical Trials - February 17, 2021
Pilloxa and University of Oslo start collaborative trial
Pilloxa has announced the start of a single-armed and multicenter observational clinical trial in which their digital patient-centric adherence solution will be tested in patients with cardiovascular disease, namely newly diagnosed patients with atrial fibrillation. The study, ASTORIA, to be conducted as a multicenter trial with the University of Oslo as lead, is funded by […]
Uncategorized - February 2, 2021
Orion invests in the development of digital therapies
Orion’s digital therapies development projects play a role in the MASSE project with the purpose to create global exports of digital health innovations. Aalto University’s MASSE project, led by Professor Paul Lillrank, brings together academic research and business-driven innovation. The project focuses on the care pathways in long-term illnesses and how they could be improved and scaled […]
